Simmons Comprehensive Cancer Center - Administration - Directors Office - Administration

Research output

Research output per year 1982 2019 2020 2021 2022 2023 2024

• 485 Article
• 53 Review article
• 31 Comment/debate
• 13 Editorial
• 23 More
  • 8 Letter
  • 5 Chapter
  • 5 Conference contribution
  • 5 Short survey

Research output per year

Research output per year

Search results

• Article

  Pretreatment with vitamin A inhibits transforming growth factor alpha stimulation of human mammary carcinoma cells

  Halter, S. A., Winnier, A. R. & Arteaga, C. L., Jul 1993, In: Journal of cellular physiology. 156, 1, p. 80-87 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Retinol 100%
  • Vitamin A 98%
  • Transforming Growth Factor alpha 96%
  • phospholipase C1 55%
  • Breast Neoplasms 48%
  9 Scopus citations

• Prevalence and correlates of false-positive results after 3-D screening mammography among uninsured women in a community outreach program

  Nair, R. G., Lee, S. J. C., Zhu, H., Arjmandi, F. K., Berry, E., Argenbright, K. E., Tiro, J. A. & Skinner, C. S., Jun 2022, In: Preventive Medicine Reports. 27, 101790.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Community-Institutional Relations 100%
  • Mammography 72%
  • age group 46%
  • Patient Navigation 41%
  • Age Groups 39%

• Prevalence of Forceps Polypectomy of Nondiminutive Polyps Is Substantial But Modifiable

  Fudman, D. I., Singal, A. G., Cooper, M. G., Lee, M. J. & Murphy, C. C., Jul 2022, In: Clinical Gastroenterology and Hepatology. 20, 7, p. 1508-1515 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Polyps 100%
  • Surgical Instruments 95%
  • Odds Ratio 29%
  • Confidence Intervals 22%
  • Gastroenterologists 18%
  1 Scopus citations

• P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer

  Dillon, L. M., Bean, J. R., Yang, W., Shee, K., Symonds, L. K., Balko, J. M., McDonald, W. H., Liu, S., Gonzalez-Angulo, A. M., Mills, G. B., Arteaga, C. L. & Miller, T. W., Jul 23 2015, In: Oncogene. 34, 30, p. 3968-3976 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Growth Factor Receptors 100%
  • Mitogen-Activated Protein Kinase Kinases 92%
  • Phosphatidylinositol 3-Kinase 86%
  • Breast Neoplasms 54%
  • Tensins 20%
  64 Scopus citations

• Primary care provider beliefs and recommendations about colorectal cancer screening in four healthcare systems

  Ghai, N. R., Jensen, C. D., Merchant, S. A., Schottinger, J. E., Lee, J. K., Chubak, J., Kamineni, A., Halm, E. A., Skinner, C. S., Haas, J. S., Green, B. B., Cannizzaro, N. T., Schneider, J. L. & Corley, D. A., Nov 1 2020, In: Cancer Prevention Research. 13, 11, p. 947-958 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Early Detection of Cancer 100%
  • Colonoscopy 89%
  • Colorectal Neoplasms 83%
  • Primary Health Care 82%
  • Delivery of Health Care 64%
  5 Scopus citations

• Prior Frequent Emergency Department Use as a Predictor of Emergency Department Visits after a New Cancer Diagnosis

  Hong, A. S., Nguyen, D. Q., Lee, S. C., Courtney, D. M., Sweetenham, J. W., Sadeghi, N., Cox, J. V., Fullington, H. & Halm, E. A., Nov 1 2021, In: JCO Oncology Practice. 17, 11, p. E1738-E1752

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hospital Emergency Service 88%
  • incidence 46%
  • Neoplasms 35%
  • Incidence 26%
  • Safety-net Providers 11%
  4 Scopus citations

• PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer

  Lin, C. C., Chang, T. C., Wang, Y., Guo, L., Gao, Y., Bikorimana, E., Lemoff, A., Fang, Y. V., Zhang, H., Zhang, Y., Ye, D., Soria-Bretones, I., Servetto, A., Lee, K. M., Luo, X., Otto, J. J., Akamatsu, H., Napolitano, F., Mani, R., Cescon, D. W., & 5 othersXu, L., Xie, Y., Mendell, J. T., Hanker, A. B. & Arteaga, C. L., Dec 2024, In: Nature communications. 15, 1, 2287.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Protein-Arginine N-Methyltransferases 100%
  • inhibitors 75%
  • breast 68%
  • Arginine 65%
  • cancer 61%

• Proapoptotic activity of cell-permeable anti-Akt single-chain antibodies

  Shin, I., Edl, J., Biswas, S., Lin, P. C., Mernaugh, R. & Arteaga, C. L., Apr 1 2005, In: Cancer research. 65, 7, p. 2815-2824 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Single-Chain Antibodies 100%
  • Glutathione Transferase 82%
  • Phosphotransferases 48%
  • Membranes 46%
  • 1-Phosphatidylinositol 4-Kinase 23%
  50 Scopus citations

• Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference summary statement

  Come, S. E., Buzdar, A. U., Ingle, J. N., Arteaga, C. L., Brown, M., Dowsett, M., Hilsenbeck, S. G., Kumar, R., Johnston, S. R. D., Lee, A. V., Paik, S., Pritchard, K. I., Winer, E. P. & Hart, C., Feb 1 2006, In: Clinical Cancer Research. 12, 3 II, p. 997s-1000s

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference summary statement

  Come, S. E., Buzdar, A. U., Ingle, J. N., Arteaga, C. L., Brodie, A. M., Colditz, G. A., Johnston, S. R. D., Kristensen, V. N., Lønning, P. E., McDonnell, D. P., Osborne, C. K., Russo, J., Santen, R. J., Yee, D. & Hart, C. S., Jan 15 2005, In: Clinical Cancer Research. 11, 2 II, p. 861s-864s

  Research output: Contribution to journal › Article › peer-review

  • Aromatase Inhibitors 100%
  • Direction compound 97%
  • Breast Neoplasms 85%
  • Congresses 79%
  • Translational Medical Research 60%
  2 Scopus citations

• Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement

  Come, S. E., Buzdar, A. U., Arteaga, C. L., Bissell, M. J., Brown, M. A., Ellis, M. J., Goss, P. E., Green, J. E., Ingle, J. N., Lee, A. V., Medina, D., Nicholson, R. I., Santen, R. J., Schiff, R. & Hart, C. S., Jan 28 2004, In: Clinical Cancer Research. 10, 1 II, p. 327s-330s

  Research output: Contribution to journal › Article › peer-review
  9 Scopus citations

• Processing of the transforming growth factor β type I and II receptors. Biosynthesis and ligand-induced regulation

  Koli, K. M. & Arteaga, C. L., Mar 7 1997, In: Journal of Biological Chemistry. 272, 10, p. 6423-6427 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Prothrombin 100%
  • Transforming Growth Factors 89%
  • Fibrinogen 81%
  • Biosynthesis 71%
  • Ligands 60%
  57 Scopus citations

• Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

  Balko, J. M., Cook, R. S., Vaught, D. B., Kuba, M. G., Miller, T. W., Bhola, N. E., Sanders, M. E., Granja-Ingram, N. M., Joshua Smith, J., Meszoely, I. M., Salter, J., Dowsett, M., Stemke-Hale, K., González-Angulo, A. M., Mills, G. B., Pinto, J. A., Gómez, H. L. & Arteaga, C. L., Jul 2012, In: Nature medicine. 18, 7, p. 1052-1059 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • protein phosphatase 4 100%
  • Dual-Specificity Phosphatases 83%
  • Residual Neoplasm 57%
  • Drug Resistance 49%
  • Breast Neoplasms 34%
  211 Scopus citations

• Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer

  Kim, H. J., Cui, X., Hilsenbeck, S. G., Lee, A. V., Dowsett, M., Pritchard, K., Come, S., Ingle, J., Paik, S., Buzdar, A. & Arteaga, C., Feb 1 2006, In: Clinical Cancer Research. 12, 3 II, p. 1013s-1018s

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • human ERBB2 protein 100%
  • Progesterone Receptors 85%
  • Estrogen Receptors 76%
  • Breast Neoplasms 52%
  • MCF-7 Cells 10%
  49 Scopus citations

• Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer

  Dowsett, M., Smith, I. E., Ebbs, S. R., Dixon, J. M., Skene, A., Griffith, C., Boeddinghaus, I., Salter, J., Detre, S., Hills, M., Ashley, S., Francis, S., Walsh, G., A'Hern, R., Arteaga, C., Buzdar, A., Ingle, J., Come, S. & Brown, M., Feb 1 2006, In: Clinical Cancer Research. 12, 3 II, p. 1024s-1030s

  Research output: Contribution to journal › Article › peer-review

  • Anastrozole 100%
  • Neoadjuvant Therapy 99%
  • Tamoxifen 91%
  • Breast Neoplasms 55%
  • Apoptosis 52%
  100 Scopus citations

• Protein kinase C ε translocation and phosphorylation by cis- diamminedichloroplatinum(II) (CDDP): Potential role in CDDP-mediated cytotoxicity

  Ohmori, T. & Arteaga, C. L., 1998, In: Cell Growth and Differentiation. 9, 4, p. 345-353 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Protein Kinase C 100%
  • Cisplatin 95%
  • Phosphorylation 73%
  • Isoenzymes 47%
  • Nuclear Envelope 26%
  16 Scopus citations

• Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses

  Del Vecchio, N. J., Beaber, E. F., Garcia, M. P., Wheeler, C. M., Kamineni, A., Chao, C., Chubak, J., Corley, D. A., Owens, C. L., Winer, R. L., Pruitt, S. L., Raine-Bennett, T., Feldman, S. & Silverberg, M., Apr 1 2023, In: Journal of Lower Genital Tract Disease. 27, 2, p. 113-119 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Biopsy 100%
  • Pathologists 71%
  • Cervical Intraepithelial Neoplasia 66%
  • Odds Ratio 47%
  • Monte Carlo Method 26%

• Provider perspectives on communication and dismissal policies with HPV vaccine hesitant parents

  Francis, J. K. R., Rodriguez, S. A., Dorsey, O., Blackwell, J. M., Balasubramanian, B. A., Kale, N., Day, P., Preston, S. M., Thompson, E. L., Pruitt, S. L. & Tiro, J. A., Dec 2021, In: Preventive Medicine Reports. 24, 101562.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • communication policy 100%
  • Papillomavirus Vaccines 91%
  • dismissal 86%
  • Parents 54%
  • Communication 54%
  8 Scopus citations

• Qualitative Exploration of Family Influences on Physical Activity in Hispanic Families

  John, J. C., Heredia, N. I., McNeill, L. H., Hoelscher, D. M., Schembre, S. M., Lee, M. J., Opusunju, J. J., Goetz, M., Aguirre, M., Reininger, B. M. & Strong, L. L., Feb 2022, In: Journal of Physical Activity and Health. 19, 2, p. 89-98 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Hispanic Americans 100%
  • dyad 78%
  • Exercise 67%
  • Acculturation 23%
  • responsibility 22%
  2 Scopus citations

• Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer

  Walsh, A. J., Cook, R. S., Sanders, M. E., Aurisicchio, L., Ciliberto, G., Arteaga, C. L. & Skala, M. C., Aug 6 2014, In: Cancer research. 74, 18, p. 5184-5194 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Organoids 100%
  • Optical Imaging 83%
  • Breast Neoplasms 48%
  • Pharmaceutical Preparations 31%
  • Neoplasms 24%
  232 Scopus citations

• Racial and Ethnic Disparities in Access to Local Anesthesia for Inguinal Hernia Repair

  Meier, J., Stevens, A., Berger, M., Hogan, T. P., Reisch, J., Cullum, C. M., Lee, S. C., Skinner, C. S., Zeh, H., Brown, C. J. & Balentine, C. J., Oct 2021, In: Journal of Surgical Research. 266, p. 366-372 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Inguinal Hernia 100%
  • Herniorrhaphy 95%
  • Local Anesthesia 90%
  • African Americans 57%
  • Hispanic Americans 35%
  4 Scopus citations

• Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings

  Spencer, J. C., Kim, J. J., Tiro, J. A., Feldman, S. J., Kobrin, S. C., Skinner, C. S., Wang, L., McCarthy, A. M., Atlas, S. J., Pruitt, S. L., Silver, M. I. & Haas, J. S., Oct 2023, In: American Journal of Preventive Medicine. 65, 4, p. 667-677 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Early Detection of Cancer 100%
  • Uterine Cervical Neoplasms 97%
  • Healthcare 81%
  • Delivery of Health Care 64%
  • insurance 50%
  7 Scopus citations

• Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States

  Tavakkoli, A., Singal, A. G., Waljee, A. K., Elmunzer, B. J., Pruitt, S. L., McKey, T., Rubenstein, J. H., Scheiman, J. M. & Murphy, C. C., Jan 2020, In: Clinical Gastroenterology and Hepatology. 18, 1, p. 171-178.e10

  Research output: Contribution to journal › Article › peer-review

  • Pancreatic Neoplasms 100%
  • Mortality 53%
  • Incidence 51%
  • African Continental Ancestry Group 28%
  • European Continental Ancestry Group 26%
  66 Scopus citations

• Racism and cancer screening among low-income, african american women: A multilevel, longitudinal analysis of 2-1-1 texas callers

  Ibekwe, L. N., Fernández-Esquer, M. E., Pruitt, S. L., Ranjit, N. & Fernández, M. E., Nov 1 2021, In: International journal of environmental research and public health. 18, 21, 11267.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • racism 100%
  • Racism 82%
  • African American 80%
  • Multilevel Analysis 77%
  • woman 55%
  5 Scopus citations

• Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

  Mayer, I. A., Zhao, F., Arteaga, C. L., Symmans, W. F., Park, B. H., Burnette, B. L., Tevaarwerk, A. J., Garcia, S. F., Smith, K. L., Makower, D. F., Block, M., Morley, K. A., Jani, C. R., Mescher, C., Dewani, S. J., Tawfik, B., Flaum, L. E., Mayer, E. L., Sikov, W. M., Rodler, E. T., & 5 othersWagner, L. I., DeMichele, A. M., Sparano, J. A., Wolff, A. C. & Miller, K. D., Aug 10 2021, In: Journal of Clinical Oncology. 39, 23, p. 2539-2551 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Capecitabine 100%
  • Triple Negative Breast Neoplasms 95%
  • Platinum 83%
  • Disease-Free Survival 46%
  • Drug Therapy 46%
  82 Scopus citations

• RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors

  Loi, S., Dushyanthen, S., Beavis, P. A., Salgado, R., Denkert, C., Savas, P., Combs, S., Rimm, D. L., Giltnane, J. M., Estrada, M. V., Sánchez, V., Sanders, M. E., Cook, R. S., Pilkinton, M. A., Mallal, S. A., Wang, K., Miller, V. A., Stephens, P. J., Yelensky, R., Doimi, F. D., & 5 othersGómez, H., Ryzhov, S. V., Darcy, P. K., Arteaga, C. L. & Balko, J. M., Mar 15 2016, In: Clinical Cancer Research. 22, 6, p. 1499-1509 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tumor-Infiltrating Lymphocytes 100%
  • Triple Negative Breast Neoplasms 95%
  • Mitogen-Activated Protein Kinase Kinases 85%
  • Breast Neoplasms 25%
  • Immune Evasion 24%
  416 Scopus citations

• Receipt of colonoscopy following diagnosis of advanced adenomas: An analysis within integrated healthcare delivery systems

  PROSPR consortium, Jan 2019, In: Cancer Epidemiology Biomarkers and Prevention. 28, 1, p. 91-98 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Integrated Delivery of Health Care 100%
  • Colonoscopy 71%
  • Adenoma 65%
  • Delivery of Health Care 42%
  • Villous Adenoma 17%
  18 Scopus citations

• Reduction of cytosolic p27^Kip1 inhibits cancer cell motility, survival, and tumorigenicity

  Wu, F. Y., Wang, S. E., Sanders, M. E., Shin, I., Rojo, F., Baselga, J. & Arteaga, C. L., Feb 15 2006, In: Cancer research. 66, 4, p. 2162-2172 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Cell Movement 100%
  • Cell Survival 92%
  • RNA Interference 46%
  • Survival 40%
  • Neoplasms 39%
  121 Scopus citations

• Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group

  Hibbitts, E., Chi, Y. Y., Hawkins, D. S., Barr, F. G., Bradley, J. A., Dasgupta, R., Meyer, W. H., Rodeberg, D. A., Rudzinski, E. R., Spunt, S. L., Skapek, S. X., Wolden, S. L. & Arndt, C. A. S., Oct 1 2019, In: Cancer Medicine. 8, 14, p. 6437-6448 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rhabdomyosarcoma 100%
  • Progression-Free Survival 54%
  • Child 36%
  • Survival 26%
  • Clinical Trials 15%
  87 Scopus citations

• Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States

  Tavakkoli, A., Singal, A. G., Waljee, A. K., Scheiman, J. M., Murphy, C. C., Pruitt, S. L., Xuan, L., Kwon, R. S., Law, R. J., Elta, G. H., Wright-Slaughter, P., Valley, T. S., Kubiliun, N., Nathan, H., Rubenstein, J. H. & Elmunzer, B. J., Jul 2019, In: Cancer Medicine. 8, 7, p. 3420-3427 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Endoscopic Retrograde Cholangiopancreatography 100%
  • Pancreatic Neoplasms 83%
  • Drainage 18%
  • Medicare 11%
  • Decompression 10%
  9 Scopus citations

• Regulation of breast cancer growth by insulin-like growth factors

  Kent Osborne, C., Clemmons, D. R. & Arteaga, C. L., Dec 20 1990, In: Journal of Steroid Biochemistry and Molecular Biology. 37, 6, p. 805-809 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Growth Stimulation 100%
  • Conditioned Culture Medium 86%
  • Growth Factor 68%
  • Estrogen 62%
  • Somatomedins 61%
  93 Scopus citations

• Regulatory Nodes That Integrate and Coordinate Signaling As Potential Targets for Breast Cancer Therapy

  Cui, X., Lee, A. V., Green, J., Nicholson, R., Brown, M., Medina, D., Ellis, M., Arteaga, C. & Bissell, M., Jan 28 2004, In: Clinical Cancer Research. 10, 1 II, p. 396s-401s

  Research output: Contribution to journal › Article › peer-review

  • Breast Neoplasms 100%
  • Estrogen Receptor Modulators 89%
  • Estrogen Receptors 81%
  • Therapeutics 25%
  • Aromatase Inhibitors 21%
  9 Scopus citations

• Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual

  Lee, S. J. C., Murphy, C. C., Gerber, D. E., Geiger, A. M., Halm, E., Nair, R. G., Cox, J. V., Tiro, J. A. & Skinner, C. S., May 2021, In: Medical Care. 59, 5, p. 461-466 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Oncologists 100%
  • Clinical Trials 95%
  • Conflict of Interest 77%
  • physician 68%
  • conflict of interest 66%
  1 Scopus citations

• Relocating job wise? A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

  Hinow, P., Wang, S. E., Arteaga, C. L. & Webb, G. F., 2007, In: Theoretical Biology and Medical Modelling. 4, 14.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lapatinib 100%
  • Inhibitor 88%
  • Cytostatic Agents 80%
  • Protein-Tyrosine Kinases 64%
  • Theoretical Models 57%
  25 Scopus citations

• Residence in a hispanic enclave is associated with inferior overall survival among children with acute lymphoblastic leukemia

  Schraw, J. M., Peckham-Gregory, E. C., Hughes, A. E., Scheurer, M. E., Pruitt, S. L. & Lupo, P. J., Sep 2021, In: International journal of environmental research and public health. 18, 17, 9273.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • leukemia 100%
  • enclave 92%
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 75%
  • Hispanic Americans 73%
  • Hazards 67%
  4 Scopus citations

• Residence in a Latinx enclave and end-induction minimal residual disease positivity among children with acute lymphoblastic leukemia

  Muñiz, J. P., Woodhouse, J. P., Hughes, A. E., Pruitt, S. L., Rabin, K. R., Scheurer, M. E., Lupo, P. J. & Schraw, J. M., 2022, In: Pediatric Hematology and Oncology. 39, 7, p. 650-657 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Residual Neoplasm 100%
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 92%
  • Child 40%
  • Survival 26%
  • Language 18%
  1 Scopus citations

• Resistin levels decrease as insulin resistance increases in a Mexican-American cohort

  Gutierrez, A. D., Flores, C. A., Naik, S., Lee, M. J., Asgarisabet, P., Resman, M., Lee, M., McCormick, J. B. & Fisher-Hoch, S. P., Dec 2021, In: Cytokine. 148, 155687.

  Research output: Contribution to journal › Article › peer-review

  • Resistin 100%
  • Mexican Americans 57%
  • Insulin Derivative 45%
  • Insulin Resistance 36%
  • Resistance 28%
  2 Scopus citations

• Reversal of tamoxifen resistance of human breast carcinomas in Vivo by neutralizing antibodies to transforming growth factor-β

  Arteaga, C. L., Koli, K. M., Dugger, T. C. & Clarke, R., Jan 6 1999, In: Journal of the National Cancer Institute. 91, 1, p. 46-53 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tamoxifen 100%
  • Transforming Growth Factors 98%
  • Neutralizing Antibodies 94%
  • Breast Neoplasms 60%
  • Nude Mice 20%
  65 Scopus citations

• Reversible G₁ arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity

  Busse, D., Doughty, R. S., Ramsey, T. T., Russell, W. E., Price, J. O., Flanagan, W. M., Shawver, L. K. & Arteaga, C. L., Mar 10 2000, In: Journal of Biological Chemistry. 275, 10, p. 6987-6995 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ErbB Receptors 100%
  • Tyrosine 95%
  • Protein-Tyrosine Kinases 95%
  • Up-Regulation 75%
  • RTKI cpd 62%
  199 Scopus citations

• Revisiting Exclusion of Prior Cancer in Clinical Trials of Male Breast Cancer

  Rathod, A., Murphy, C. C., Rahimi, A. & Pruitt, S. L., 2023, In: Journal of Cancer. 14, 5, p. 737-740 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Male Breast Neoplasms 100%
  • Clinical Trials 45%
  • Neoplasms 22%
  • Breast Neoplasms 16%
  • SEER Program 6%

• Ribociclib as first-line therapy for HR-positive, advanced breast cancer

  Hortobagyi, G. N., Stemmer, S. M., Burris, H. A., Yap, Y. S., Sonke, G. S., Paluch-Shimon, S., Campone, M., Blackwell, K. L., Andre, F., Winer, E. P., Janni, W., Verma, S., Conte, P., Arteaga, C. L., Cameron, D. A., Petrakova, K., Hart, L. L., Villanueva, C., Chan, A., Jakobsen, E., & 17 othersNusch, A., Burdaeva, O., Grischke, E. M., Alba, E., Wist, E., Marschner, N., Favret, A. M., Yardley, D., Bachelot, T., Tseng, L. M., Blau, S., Xuan, F., Souami, F., Miller, M., Germa, C., Hirawat, S. & O'Shaughnessy, J., Nov 3 2016, In: New England Journal of Medicine. 375, 18, p. 1738-1748 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ribociclib 100%
  • Letrozole 55%
  • Hormones 39%
  • Breast Neoplasms 36%
  • Placebos 33%
  1304 Scopus citations

• Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial

  O’Shaughnessy, J., Petrakova, K., Sonke, G. S., Conte, P., Arteaga, C. L., Cameron, D. A., Hart, L. L., Villanueva, C., Jakobsen, E., Beck, J. T., Lindquist, D., Souami, F., Mondal, S., Germa, C. & Hortobagyi, G. N., Feb 1 2018, In: Breast Cancer Research and Treatment. 168, 1, p. 127-134 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ribociclib 100%
  • Letrozole 78%
  • Breast Neoplasms 36%
  • Progression-Free Survival 22%
  • Placebos 17%
  84 Scopus citations

• RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells

  Bauer, J. A., Ye, F., Marshall, C. B., Lehmann, B. D., Pendleton, C. S., Shyr, Y., Arteaga, C. L. & Pietenpol, J. A., Jun 24 2010, In: Breast Cancer Research. 12, 3, R41.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Paclitaxel 100%
  • RNA Interference 94%
  • Breast Neoplasms 63%
  • CCT007093 38%
  • Triple Negative Breast Neoplasms 29%
  64 Scopus citations

• Role of molecular and genetic markers in breast cancer treatment decisions

  Osborne, C. K. & Arteaga, C. L., Dec 1 2003, In: Journal of Clinical Oncology. 21, 23, p. 285s-287s

  Research output: Contribution to journal › Article › peer-review
  7 Scopus citations

• Scaling a Community-Wide Campaign Intervention to Manage Hypertension and Weight Loss

  Reininger, B. M., Mitchell-Bennett, L. A., Lee, M. J., Yeh, P. G., Davé, A. C., Park, S. K., Xu, T. & Ochoa-Del Toro, A. G., Nov 22 2021, In: Frontiers in Medicine. 8, 661353.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Weight Loss 100%
  • Hypertension 78%
  • Blood Pressure 77%
  • Hispanic Americans 50%
  • Linear Models 40%
  4 Scopus citations

• Screening for colorectal cancer in a safety-net health care system: Access to care is critical and has implications for screening policy

  Gupta, S., Tong, L., Allison, J. E., Carter, E., Koch, M., Rockey, D. C., Anderson, P., Ahn, C., Argenbright, K. & Skinner, C. S., Sep 2009, In: Cancer Epidemiology Biomarkers and Prevention. 18, 9, p. 2373-2379 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Critical Care 100%
  • Colorectal Neoplasms 90%
  • Delivery of Health Care 69%
  • Safety 66%
  • Insurance Coverage 66%
  24 Scopus citations

• Second international conference on recent advances and future directions in endocrine manipulation of breast cancer: Summary consensus statement

  Come, S. E., Buzdar, A. U., Arteaga, C. L., Brodie, A. M., Davidson, N. E., Dowsett, M., Ingle, J. N., Johnston, S. R. D., Lee, A. V., Osborne, C. K., Pritchard, K. I., Vogel, V. G., Winer, E. P. & Hart, C. S., Jan 1 2003, In: Clinical Cancer Research. 9, 1 II, p. 443s-446s

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing

  Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A. & Siegwart, D. J., Apr 1 2020, In: Nature Nanotechnology. 15, 4, p. 313-320 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • editing 100%
  • Messenger RNA 96%
  • genes 80%
  • organs 70%
  • Nanoparticles 67%
  883 Scopus citations

• Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

  Wang, A., Lee, M. J., Keller, A., Jian, S., Lowe, K., Finklea, J. D. & Jain, R., Jan 2024, In: Journal of Cystic Fibrosis. 23, 1, p. 91-98 8 p.

  Research output: Contribution to journal › Article › peer-review

  • tezacaftor; ivacaftor 100%
  • Cystic Fibrosis 46%
  • Sex Characteristics 44%
  • Lung 8%
  • Pseudomonas aeruginosa 7%
  3 Scopus citations

• Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers

  Guix, M., Granja, N. D. M., Meszoely, I., Adkins, T. B., Wieman, B. M., Frierson, K. E., Sanchez, V., Sanders, M. E., Grau, A. M., Mayer, I. A., Pestano, G., Shyr, Y., Muthuswamy, S., Calvo, B., Krontiras, H., Krop, I. E., Kelley, M. C. & Arteaga, C. L., Feb 20 2008, In: Journal of Clinical Oncology. 26, 6, p. 897-906 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Erlotinib Hydrochloride 100%
  • Hormones 55%
  • human ERBB2 protein 55%
  • Cell Proliferation 51%
  • Breast Neoplasms 50%
  95 Scopus citations